Profile data is unavailable for this security.
About the company
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
- Revenue in JPY (TTM)491.29bn
- Net income in JPY53.45bn
- Incorporated1968
- Employees10.04k
- LocationSysmex Corp1-5-1, Wakinohama Kaigandori, Chuo-kuKOBE-SHI 651-0073JapanJPN
- Phone+81 782650500
- Fax+81 782650524
- Websitehttps://www.sysmex.co.jp/
More ▼
Mergers & acquisitions
| Acquired company | 6869:TYO since announced | Transaction value |
|---|---|---|
| Megakaryon Corp | 19.92% | -- |
Data delayed at least 20 minutes, as of Nov 21 2024 06:30 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sysmex Corp | 491.29bn | 53.45bn | 1.93tn | 10.04k | 35.87 | 4.34 | 21.12 | 3.94 | 85.64 | 85.64 | 787.09 | 707.21 | 0.8356 | 2.80 | 3.67 | 48,923,520.00 | 9.11 | 8.92 | 11.11 | 11.29 | 53.49 | 52.27 | 10.90 | 11.19 | 2.42 | 9.63 | 0.1119 | 39.12 | 12.43 | 9.47 | 8.42 | 3.79 | 11.61 | 3.71 |
| Cochlear Ltd | 226.06bn | 36.08bn | 1.97tn | 5.00k | 54.89 | 10.60 | 44.16 | 8.73 | 5.43 | 5.43 | 34.02 | 28.10 | 0.8414 | 1.54 | 4.82 | 447,120.00 | 13.43 | 8.55 | 17.39 | 11.15 | 75.84 | 75.05 | 15.96 | 11.98 | 1.68 | -- | 0.1169 | 91.14 | 15.47 | 9.40 | 18.70 | 5.22 | -4.76 | 4.44 |
| Fisher & Paykel Healthcare Corporatn Ltd | 159.16bn | 12.11bn | 1.98tn | 7.14k | 163.59 | 12.30 | 88.00 | 12.47 | 0.2266 | 0.2266 | 2.97 | 3.01 | 0.777 | 2.04 | 7.33 | 244,055.50 | 5.91 | 16.43 | 6.96 | 19.83 | 59.93 | 62.09 | 7.61 | 19.07 | 0.9987 | 18.03 | 0.0971 | 49.48 | 10.23 | 10.24 | -47.02 | -8.72 | 20.52 | 12.29 |
| Pro Medicus Limited | 16.82bn | 8.37bn | 2.27tn | 79.00 | 271.35 | 119.38 | 245.64 | 134.84 | 0.7909 | 0.7909 | 1.59 | 1.80 | 0.7239 | 5.79 | 3.72 | -- | 36.03 | 32.19 | 42.01 | 37.84 | 99.82 | 99.58 | 49.78 | 47.15 | 5.98 | 104.83 | 0.0109 | 33.66 | 30.63 | 27.00 | 36.52 | 34.05 | -2.38 | 37.97 |
| Shanghai United Img Hlthcare Co Ltd | 234.52bn | 33.92bn | 2.54tn | 7.44k | 74.67 | 6.16 | -- | 10.83 | 1.92 | 1.92 | 13.33 | 23.33 | 0.4349 | 1.14 | 3.17 | 1,469,437.00 | 6.25 | -- | 8.16 | -- | 48.41 | -- | 14.37 | -- | 2.27 | -- | 0.0263 | -- | 23.52 | -- | 19.21 | -- | -- | -- |
Data as of Nov 21 2024. Currency figures normalised to Sysmex Corp's reporting currency: Japanese Yen JPY
21.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baillie Gifford & Co.as of 31 Jan 2024 | 31.24m | 4.96% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 19.02m | 3.02% |
| Nomura Asset Management Co., Ltd.as of 07 Nov 2024 | 18.66m | 2.97% |
| Harding Loevner LPas of 30 Sep 2024 | 13.77m | 2.19% |
| BlackRock Fund Advisorsas of 07 Nov 2024 | 10.68m | 1.70% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 8.69m | 1.38% |
| Walter Scott & Partners Ltd.as of 14 Nov 2024 | 8.32m | 1.32% |
| Nikko Asset Management Co., Ltd.as of 08 Nov 2024 | 7.99m | 1.27% |
| Daiwa Asset Management Co. Ltd.as of 31 Oct 2024 | 7.77m | 1.24% |
| Invesco Advisers, Inc.as of 07 Nov 2024 | 6.24m | 0.99% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
